BMSC-derived exosomal ANTXR1 inhibits erythroid differentiation by suppressing the TLR4/MyD88/NF-κB signaling pathway

  • Sci Rep. 2026 Apr 16;16(1):19999. doi: 10.1038/s41598-026-47662-9.
Dengyun Chen  1 ,  Liping Lin  2 ,  Yibo Wu  1 ,  Kunbo Huang  1 ,  Hanhui Zhang  1 ,  Qingqing Chen  3
Affiliations
  • 1. Clinical Laboratory, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, 362000, China.
  • 2. Blood Transfusion Department, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, 362000, China.
  • 3. Clinical Laboratory, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, 362000, China. [email protected].
PMID: 41992002 DOI: 10.1038/s41598-026-47662-9
Abstract

Aplastic anemia (AA) is a bone marrow failure syndrome characterized by impaired hematopoiesis and a dysfunctional marrow microenvironment. Bone marrow-derived mesenchymal stem cell (BMSC)-derived exosomes play a crucial role in intercellular communication; however, the role of exosomal anthrax toxin receptor 1 (ANTXR1) in erythroid differentiation remains unclear. Mouse BMSCs were isolated, characterized, and transfected with either ANTXR1-overexpressing or ANTXR1-silencing lentiviral vectors. Exosomes were collected and identified using transmission electron microscopy, nanoparticle tracking analysis, and exosomal marker detection. K562 cells and human cord blood CD34⁺cells were treated with these exosomes. Erythroid differentiation was evaluated through flow cytometry for CD235a and CD71, benzidine staining, RT-qPCR, and Western blot analysis of GATA1 and ALAS2. Apoptosis and inflammatory signaling were examined using flow cytometry, ELISA, Western blotting, and co-immunoprecipitation. TLR4 Inhibitor and agonist treatments were applied to verify pathway involvement. BMSC-derived exosomes successfully carried ANTXR1, and their abundance reflected ANTXR1 expression in donor BMSCs. Exosomes enriched in ANTXR1 inhibited erythroid differentiation, as evidenced by reduced CD235a/CD71 expression, decreased GATA1 and ALAS2 levels, and diminished Hemoglobin synthesis. In contrast, ANTXR1-deficient exosomes promoted erythroid differentiation and Apoptosis while activating the TLR4/MyD88/NF-κB pathway. Pharmacological inhibition of TLR4 attenuated these effects, whereas TLR4 Agonist treatment enhanced them. Co-immunoprecipitation further supported an interaction between ANTXR1 and TLR4. BMSC-derived exosomal ANTXR1 suppresses erythroid differentiation, at least in part, by modulating the TLR4/MyD88/NF-κB signaling pathway. These findings identify exosomal ANTXR1 as a potential regulator of erythropoiesis.

Supplementary Information: The online version contains supplementary material available at 10.1038/s41598-026-47662-9.

Keywords
ANTXR1; Aplastic anemia; Bone marrow-derived mesenchymal stem cells (BMSCs); Erythroid differentiation; Exosomes; TLR4 signaling pathway.
Products